Location History:
- Wigan, GB (2013 - 2015)
- Liverpool, GB (2017)
- Macclesfield, GB (2018 - 2023)
Company Filing History:
Years Active: 2013-2025
Title: Inder Bhamra: Innovator in Cancer Treatment
Introduction
Inder Bhamra is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target the Wnt signaling pathway. With a total of 10 patents to his name, Bhamra's work is paving the way for innovative cancer treatments.
Latest Patents
One of Bhamra's latest patents involves N-pyridinyl acetamide derivatives as inhibitors of the Wnt signaling pathway. This invention focuses on compounds that serve as inhibitors of Porcupine (Porcn), a key player in the Wnt signaling pathway. The compounds developed through this invention have potential applications in treating various conditions mediated by the Wnt signaling pathway, including cancer, sarcoma, melanoma, skin cancer, hematological tumors, lymphoma, carcinoma, and leukemia. Additionally, these compounds may enhance the effectiveness of existing anti-cancer treatments.
Career Highlights
Throughout his career, Inder Bhamra has worked with prominent companies in the pharmaceutical industry, including Redx Pharma Limited and Redx Pharma Limited. His expertise in medicinal chemistry and innovative approach to drug development have established him as a key figure in the fight against cancer.
Collaborations
Bhamra has collaborated with notable professionals in his field, including Richard Testar and Craig Donoghue. These collaborations have further enriched his research and development efforts, contributing to the advancement of cancer therapies.
Conclusion
Inder Bhamra's innovative work in developing inhibitors of the Wnt signaling pathway showcases his commitment to advancing cancer treatment. His contributions through patents and collaborations highlight the importance of research in the pharmaceutical industry.